IHE:NYE-iShares U.S. Pharmaceuticals ETF (USD)

ETF | Health |

Last Closing

USD 71.8607

Change

0.00 (0.00)%

Market Cap

N/A

Volume

0.24M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-20 )

ETFs Containing IHE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -61.24% 24% F 7% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return -61.24% 24% F 11% F
Trailing 12 Months  
Capital Gain -58.85% 19% F 6% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return -58.85% 19% F 9% A-
Trailing 5 Years  
Capital Gain -48.97% 24% F 14% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -48.97% 24% F 20% F
Average Annual (5 Year Horizon)  
Capital Gain 5.56% 48% F 56% F
Dividend Return 6.91% 57% F 53% F
Total Return 1.36% 100% F 31% F
Risk Return Profile  
Volatility (Standard Deviation) 13.07% 71% C- 70% C-
Risk Adjusted Return 52.92% 71% C- 70% C-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike